Patricia Ernst
Concepts (304)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myeloid-Lymphoid Leukemia Protein | 31 | 2026 | 72 | 8.420 |
Why?
| | Histone-Lysine N-Methyltransferase | 29 | 2025 | 141 | 7.310 |
Why?
| | Leukemia | 9 | 2025 | 245 | 2.550 |
Why?
| | Hematopoiesis | 12 | 2017 | 194 | 2.430 |
Why?
| | Hematopoietic Stem Cells | 14 | 2019 | 420 | 2.300 |
Why?
| | Gene Rearrangement | 5 | 2026 | 155 | 2.240 |
Why?
| | Oncogene Proteins, Fusion | 8 | 2026 | 210 | 1.640 |
Why?
| | Gene Expression Regulation, Leukemic | 8 | 2026 | 56 | 1.560 |
Why?
| | Leukemia, Myeloid, Acute | 8 | 2021 | 682 | 1.420 |
Why?
| | Proto-Oncogene Proteins | 8 | 2025 | 623 | 1.290 |
Why?
| | DNA-Binding Proteins | 9 | 2025 | 1499 | 1.030 |
Why?
| | Neoplasm Proteins | 5 | 2026 | 442 | 1.020 |
Why?
| | Transcription Factors | 12 | 2025 | 1741 | 0.960 |
Why?
| | Histones | 6 | 2025 | 669 | 0.920 |
Why?
| | Epigenesis, Genetic | 3 | 2015 | 684 | 0.890 |
Why?
| | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2026 | 89 | 0.850 |
Why?
| | Morals | 1 | 2025 | 80 | 0.820 |
Why?
| | B-Lymphocytes | 3 | 2018 | 876 | 0.640 |
Why?
| | Cell Transformation, Neoplastic | 4 | 2021 | 339 | 0.620 |
Why?
| | Animals | 44 | 2026 | 38058 | 0.590 |
Why?
| | Health Personnel | 1 | 2025 | 748 | 0.550 |
Why?
| | Antineoplastic Agents | 3 | 2025 | 2194 | 0.550 |
Why?
| | Proto-Oncogenes | 5 | 2005 | 29 | 0.550 |
Why?
| | Sirtuin 1 | 2 | 2015 | 34 | 0.550 |
Why?
| | Methyltransferases | 2 | 2016 | 74 | 0.540 |
Why?
| | Mice | 35 | 2026 | 18339 | 0.530 |
Why?
| | Interleukin-7 | 1 | 2018 | 65 | 0.530 |
Why?
| | Immunotherapy, Adoptive | 1 | 2021 | 337 | 0.530 |
Why?
| | Cell Differentiation | 9 | 2025 | 2050 | 0.520 |
Why?
| | Histone Chaperones | 1 | 2016 | 15 | 0.500 |
Why?
| | Methylation | 8 | 2025 | 242 | 0.480 |
Why?
| | Hematologic Neoplasms | 1 | 2017 | 161 | 0.450 |
Why?
| | Cell Proliferation | 11 | 2019 | 2496 | 0.430 |
Why?
| | Leukemia, Experimental | 1 | 2014 | 27 | 0.430 |
Why?
| | Helicobacter pylori | 3 | 2001 | 45 | 0.370 |
Why?
| | Genes, Homeobox | 3 | 2006 | 50 | 0.330 |
Why?
| | Gene Regulatory Networks | 1 | 2013 | 318 | 0.330 |
Why?
| | Cells, Cultured | 12 | 2019 | 4154 | 0.320 |
Why?
| | Embryo, Mammalian | 3 | 2005 | 232 | 0.310 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2004 | 905 | 0.300 |
Why?
| | Signal Transduction | 6 | 2018 | 5226 | 0.300 |
Why?
| | Chromatin | 4 | 2016 | 561 | 0.290 |
Why?
| | Mice, Inbred C57BL | 10 | 2021 | 5992 | 0.280 |
Why?
| | Interferon-alpha | 1 | 2009 | 197 | 0.270 |
Why?
| | Interleukin-10 | 2 | 2000 | 309 | 0.270 |
Why?
| | Mice, Knockout | 10 | 2021 | 3121 | 0.260 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2019 | 293 | 0.260 |
Why?
| | Homeodomain Proteins | 8 | 2016 | 523 | 0.260 |
Why?
| | Mice, Transgenic | 6 | 2019 | 2182 | 0.260 |
Why?
| | Gene Expression Regulation | 6 | 2017 | 2608 | 0.260 |
Why?
| | Pluripotent Stem Cells | 2 | 2023 | 84 | 0.250 |
Why?
| | Stem Cells | 3 | 2009 | 626 | 0.240 |
Why?
| | Tumor Suppressor Proteins | 2 | 2021 | 321 | 0.240 |
Why?
| | Carcinogenesis | 2 | 2019 | 229 | 0.240 |
Why?
| | Humans | 32 | 2026 | 144759 | 0.240 |
Why?
| | Lymphocyte Activation | 2 | 2018 | 1126 | 0.220 |
Why?
| | Sweden | 1 | 2025 | 111 | 0.220 |
Why?
| | Intestinal Mucosa | 3 | 2000 | 676 | 0.220 |
Why?
| | Oncogene Proteins | 2 | 2016 | 61 | 0.210 |
Why?
| | Trans-Activators | 3 | 2021 | 405 | 0.210 |
Why?
| | HEK293 Cells | 4 | 2021 | 744 | 0.210 |
Why?
| | Nuclear Proteins | 2 | 2026 | 748 | 0.200 |
Why?
| | Promoter Regions, Genetic | 5 | 2023 | 1257 | 0.200 |
Why?
| | Homeostasis | 3 | 2018 | 640 | 0.200 |
Why?
| | Gastric Mucosa | 2 | 2000 | 52 | 0.200 |
Why?
| | Apoptosis | 5 | 2011 | 2430 | 0.200 |
Why?
| | fas Receptor | 2 | 2001 | 92 | 0.200 |
Why?
| | Neuronal Plasticity | 2 | 2016 | 309 | 0.190 |
Why?
| | Zinc Fingers | 1 | 2002 | 53 | 0.180 |
Why?
| | Multiprotein Complexes | 2 | 2014 | 172 | 0.180 |
Why?
| | Chromatin Assembly and Disassembly | 2 | 2014 | 109 | 0.170 |
Why?
| | Tumor Escape | 1 | 2021 | 49 | 0.170 |
Why?
| | Membrane Glycoproteins | 2 | 2001 | 496 | 0.170 |
Why?
| | Antigens, Bacterial | 1 | 2001 | 125 | 0.160 |
Why?
| | Antigens, CD19 | 1 | 2021 | 129 | 0.160 |
Why?
| | Alleles | 4 | 2014 | 879 | 0.160 |
Why?
| | Intestine, Large | 1 | 2000 | 14 | 0.160 |
Why?
| | Precursor Cells, B-Lymphoid | 2 | 2018 | 41 | 0.160 |
Why?
| | Enterotoxins | 1 | 2000 | 89 | 0.160 |
Why?
| | Receptors, Interleukin | 1 | 2000 | 43 | 0.160 |
Why?
| | Myogenic Regulatory Factor 5 | 1 | 2019 | 6 | 0.150 |
Why?
| | PAX7 Transcription Factor | 1 | 2019 | 13 | 0.150 |
Why?
| | Proto-Oncogene Proteins c-bcl-6 | 1 | 2019 | 11 | 0.150 |
Why?
| | Lymphopoiesis | 2 | 2013 | 27 | 0.150 |
Why?
| | MDS1 and EVI1 Complex Locus Protein | 1 | 2019 | 8 | 0.150 |
Why?
| | Cell Line | 7 | 2007 | 2882 | 0.150 |
Why?
| | Gene Deletion | 2 | 2019 | 389 | 0.150 |
Why?
| | Satellite Cells, Skeletal Muscle | 1 | 2019 | 32 | 0.150 |
Why?
| | Myoblasts | 1 | 2019 | 84 | 0.150 |
Why?
| | Intestine, Small | 1 | 2000 | 166 | 0.140 |
Why?
| | Core Binding Factor Alpha 2 Subunit | 2 | 2011 | 30 | 0.140 |
Why?
| | Recombinant Fusion Proteins | 2 | 2021 | 675 | 0.140 |
Why?
| | Tamoxifen | 1 | 2019 | 217 | 0.140 |
Why?
| | Flow Cytometry | 5 | 2011 | 1173 | 0.140 |
Why?
| | Multigene Family | 2 | 2017 | 204 | 0.140 |
Why?
| | T-Lymphocyte Subsets | 1 | 2000 | 415 | 0.130 |
Why?
| | Enzyme Inhibitors | 1 | 2021 | 824 | 0.130 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2019 | 675 | 0.130 |
Why?
| | Longitudinal Studies | 1 | 2025 | 2947 | 0.130 |
Why?
| | Embryonic Stem Cells | 2 | 2025 | 130 | 0.130 |
Why?
| | Female | 12 | 2025 | 78271 | 0.130 |
Why?
| | Cell Survival | 4 | 2019 | 1098 | 0.130 |
Why?
| | Neurons | 4 | 2016 | 1640 | 0.130 |
Why?
| | Protein Interaction Maps | 1 | 2016 | 51 | 0.120 |
Why?
| | Nuclear Pore Complex Proteins | 1 | 2016 | 40 | 0.120 |
Why?
| | Organ Specificity | 1 | 2017 | 312 | 0.120 |
Why?
| | Ventral Striatum | 1 | 2016 | 10 | 0.120 |
Why?
| | Dopamine Agents | 1 | 2016 | 22 | 0.120 |
Why?
| | Antigens, CD | 2 | 2013 | 555 | 0.120 |
Why?
| | Protein Binding | 2 | 2025 | 2273 | 0.120 |
Why?
| | Enhancer Elements, Genetic | 1 | 2017 | 192 | 0.120 |
Why?
| | Staphylococcus aureus | 1 | 2000 | 455 | 0.120 |
Why?
| | Chromatin Immunoprecipitation | 2 | 2013 | 139 | 0.110 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2017 | 1455 | 0.110 |
Why?
| | Neuroendocrine Tumors | 1 | 2016 | 112 | 0.110 |
Why?
| | Gene Knock-In Techniques | 1 | 2014 | 61 | 0.110 |
Why?
| | Cell Lineage | 4 | 2013 | 376 | 0.110 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2005 | 983 | 0.100 |
Why?
| | Heterografts | 1 | 2014 | 143 | 0.100 |
Why?
| | Protein Interaction Mapping | 1 | 2014 | 104 | 0.100 |
Why?
| | CD48 Antigen | 1 | 2013 | 3 | 0.100 |
Why?
| | Protein Structure, Tertiary | 2 | 2014 | 862 | 0.100 |
Why?
| | Acetyl-CoA C-Acetyltransferase | 1 | 2013 | 9 | 0.100 |
Why?
| | Leukocytosis | 1 | 2013 | 32 | 0.100 |
Why?
| | Histone Acetyltransferases | 1 | 2014 | 62 | 0.100 |
Why?
| | Infant, Newborn | 1 | 2025 | 6429 | 0.100 |
Why?
| | Epistasis, Genetic | 1 | 2013 | 66 | 0.100 |
Why?
| | Action Potentials | 1 | 2016 | 506 | 0.100 |
Why?
| | T-Lymphocytes | 1 | 2001 | 1982 | 0.100 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2014 | 226 | 0.090 |
Why?
| | Memory, Short-Term | 1 | 2015 | 271 | 0.090 |
Why?
| | Capillary Permeability | 1 | 2012 | 134 | 0.090 |
Why?
| | Bone Marrow Cells | 1 | 2013 | 320 | 0.090 |
Why?
| | Capillaries | 1 | 2012 | 124 | 0.090 |
Why?
| | Prefrontal Cortex | 1 | 2015 | 328 | 0.090 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2014 | 459 | 0.090 |
Why?
| | Protein Domains | 2 | 2025 | 313 | 0.090 |
Why?
| | Fas Ligand Protein | 2 | 2001 | 60 | 0.080 |
Why?
| | Blood Proteins | 1 | 2012 | 249 | 0.080 |
Why?
| | Lysine | 1 | 2012 | 302 | 0.080 |
Why?
| | Mice, Inbred C3H | 2 | 2000 | 251 | 0.080 |
Why?
| | Epithelial Cells | 3 | 2000 | 1125 | 0.080 |
Why?
| | Membrane Proteins | 2 | 2013 | 1166 | 0.080 |
Why?
| | Atherosclerosis | 1 | 2013 | 409 | 0.070 |
Why?
| | Tumor Cells, Cultured | 3 | 2016 | 919 | 0.070 |
Why?
| | Cell Cycle | 2 | 2011 | 596 | 0.070 |
Why?
| | Anxiety | 1 | 2016 | 1109 | 0.070 |
Why?
| | Mutation | 4 | 2015 | 4089 | 0.070 |
Why?
| | Carrier Proteins | 1 | 2012 | 737 | 0.070 |
Why?
| | Histocompatibility Antigens Class II | 2 | 2000 | 364 | 0.070 |
Why?
| | Neurodegenerative Diseases | 1 | 2010 | 151 | 0.070 |
Why?
| | Pancreatic Neoplasms | 1 | 2016 | 919 | 0.070 |
Why?
| | Erythroid Precursor Cells | 1 | 2007 | 5 | 0.070 |
Why?
| | Myeloid Progenitor Cells | 1 | 2007 | 17 | 0.070 |
Why?
| | Chimera | 1 | 2007 | 61 | 0.070 |
Why?
| | Neurogenesis | 1 | 2009 | 156 | 0.060 |
Why?
| | Sequence Deletion | 1 | 2007 | 193 | 0.060 |
Why?
| | Cell Count | 1 | 2007 | 320 | 0.060 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2007 | 396 | 0.060 |
Why?
| | Animals, Newborn | 3 | 2016 | 902 | 0.060 |
Why?
| | Middle Aged | 3 | 2025 | 35875 | 0.060 |
Why?
| | Myeloid Cells | 1 | 2007 | 148 | 0.060 |
Why?
| | Exons | 1 | 2007 | 358 | 0.060 |
Why?
| | Treatment Outcome | 1 | 2021 | 11679 | 0.060 |
Why?
| | Cognition | 1 | 2014 | 1266 | 0.060 |
Why?
| | Endothelium, Vascular | 1 | 2012 | 965 | 0.060 |
Why?
| | Bone Marrow | 1 | 2007 | 304 | 0.060 |
Why?
| | Nerve Tissue Proteins | 3 | 2016 | 592 | 0.060 |
Why?
| | Cell Death | 1 | 2007 | 383 | 0.060 |
Why?
| | Male | 7 | 2025 | 72315 | 0.060 |
Why?
| | Models, Biological | 1 | 2013 | 1821 | 0.060 |
Why?
| | Cytotoxicity, Immunologic | 2 | 2001 | 223 | 0.060 |
Why?
| | Myeloproliferative Disorders | 1 | 2005 | 19 | 0.050 |
Why?
| | Adult | 3 | 2025 | 40449 | 0.050 |
Why?
| | Mesonephros | 1 | 2004 | 3 | 0.050 |
Why?
| | Galactosides | 1 | 2004 | 9 | 0.050 |
Why?
| | Signaling Lymphocytic Activation Molecule Family | 1 | 2004 | 7 | 0.050 |
Why?
| | Killer Cells, Natural | 2 | 2004 | 467 | 0.050 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2004 | 49 | 0.050 |
Why?
| | Antigens, CD34 | 1 | 2004 | 88 | 0.050 |
Why?
| | Leukocyte Common Antigens | 1 | 2004 | 88 | 0.050 |
Why?
| | Phenotype | 4 | 2013 | 3162 | 0.050 |
Why?
| | Biomarkers | 2 | 2013 | 4271 | 0.050 |
Why?
| | Structure-Activity Relationship | 1 | 2025 | 570 | 0.050 |
Why?
| | In Situ Hybridization | 1 | 2004 | 319 | 0.050 |
Why?
| | Coculture Techniques | 1 | 2004 | 246 | 0.050 |
Why?
| | Gene Transfer Techniques | 1 | 2004 | 185 | 0.050 |
Why?
| | Cell Nucleus Structures | 1 | 2003 | 4 | 0.050 |
Why?
| | Nucleosomes | 1 | 2025 | 165 | 0.050 |
Why?
| | Cell Line, Tumor | 2 | 2021 | 3540 | 0.050 |
Why?
| | Polycomb-Group Proteins | 1 | 2023 | 36 | 0.050 |
Why?
| | Stem Cell Transplantation | 1 | 2004 | 191 | 0.050 |
Why?
| | Myeloid Ecotropic Viral Integration Site 1 Protein | 2 | 2016 | 11 | 0.050 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2016 | 758 | 0.050 |
Why?
| | Neoplastic Stem Cells | 1 | 2026 | 412 | 0.040 |
Why?
| | Mice, Inbred CBA | 2 | 2000 | 57 | 0.040 |
Why?
| | DNA | 2 | 2025 | 1463 | 0.040 |
Why?
| | Base Sequence | 2 | 2006 | 2190 | 0.040 |
Why?
| | Jurkat Cells | 1 | 2001 | 114 | 0.040 |
Why?
| | Models, Immunological | 1 | 2001 | 100 | 0.040 |
Why?
| | Aorta | 1 | 2004 | 429 | 0.040 |
Why?
| | Time Factors | 3 | 2013 | 7173 | 0.040 |
Why?
| | DNA Methylation | 1 | 2026 | 681 | 0.040 |
Why?
| | Urease | 1 | 2000 | 13 | 0.040 |
Why?
| | Oncogenes | 1 | 2021 | 119 | 0.040 |
Why?
| | Genome | 1 | 2023 | 306 | 0.040 |
Why?
| | Helicobacter Infections | 1 | 2000 | 30 | 0.040 |
Why?
| | Cytotoxicity Tests, Immunologic | 1 | 2000 | 37 | 0.040 |
Why?
| | Liver | 2 | 2011 | 1887 | 0.040 |
Why?
| | Catalytic Domain | 1 | 2021 | 232 | 0.040 |
Why?
| | Zebrafish Proteins | 1 | 2003 | 311 | 0.040 |
Why?
| | Receptors, Interleukin-10 | 1 | 2000 | 7 | 0.040 |
Why?
| | Drug Design | 1 | 2021 | 173 | 0.040 |
Why?
| | Drug Discovery | 1 | 2021 | 155 | 0.040 |
Why?
| | Indoles | 1 | 2004 | 501 | 0.040 |
Why?
| | Lymphoid Tissue | 1 | 2000 | 80 | 0.040 |
Why?
| | Immunohistochemistry | 1 | 2004 | 1716 | 0.040 |
Why?
| | Th1 Cells | 1 | 2000 | 139 | 0.040 |
Why?
| | Crystallography, X-Ray | 1 | 2021 | 492 | 0.040 |
Why?
| | Clone Cells | 1 | 2000 | 266 | 0.040 |
Why?
| | Gene Targeting | 1 | 2019 | 82 | 0.040 |
Why?
| | DNA Primers | 1 | 2000 | 512 | 0.040 |
Why?
| | Ligands | 1 | 2001 | 673 | 0.040 |
Why?
| | Gastritis | 1 | 2000 | 115 | 0.040 |
Why?
| | Zebrafish | 1 | 2003 | 528 | 0.040 |
Why?
| | Protein Biosynthesis | 1 | 2001 | 458 | 0.030 |
Why?
| | Up-Regulation | 1 | 2001 | 851 | 0.030 |
Why?
| | Immunity, Cellular | 1 | 2000 | 272 | 0.030 |
Why?
| | Loss of Heterozygosity | 1 | 2016 | 52 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2000 | 784 | 0.030 |
Why?
| | Models, Molecular | 1 | 2021 | 1618 | 0.030 |
Why?
| | Neoplasms, Experimental | 1 | 2016 | 173 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2003 | 2832 | 0.030 |
Why?
| | Locomotion | 1 | 2016 | 105 | 0.030 |
Why?
| | Immunosuppressive Agents | 1 | 2000 | 846 | 0.030 |
Why?
| | Prosencephalon | 1 | 2015 | 53 | 0.030 |
Why?
| | Bacterial Proteins | 1 | 2001 | 955 | 0.030 |
Why?
| | Pyramidal Cells | 1 | 2015 | 79 | 0.030 |
Why?
| | Cytoskeletal Proteins | 1 | 2015 | 156 | 0.030 |
Why?
| | Cell Membrane | 2 | 2012 | 706 | 0.030 |
Why?
| | Genotype | 2 | 2013 | 1833 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2015 | 336 | 0.030 |
Why?
| | Antigens, Ly | 1 | 2013 | 40 | 0.020 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2000 | 1129 | 0.020 |
Why?
| | Apolipoproteins E | 1 | 2013 | 94 | 0.020 |
Why?
| | Caveolae | 1 | 2012 | 16 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2013 | 72 | 0.020 |
Why?
| | Protein-Losing Enteropathies | 1 | 2012 | 10 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 173 | 0.020 |
Why?
| | Antipsychotic Agents | 1 | 2014 | 213 | 0.020 |
Why?
| | Cytokines | 1 | 2000 | 2061 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1313 | 0.020 |
Why?
| | Circadian Rhythm | 1 | 2016 | 514 | 0.020 |
Why?
| | Behavior, Animal | 1 | 2015 | 519 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2013 | 310 | 0.020 |
Why?
| | Cerebral Cortex | 1 | 2014 | 464 | 0.020 |
Why?
| | Integrases | 1 | 2011 | 122 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 4282 | 0.020 |
Why?
| | Schizophrenia | 1 | 2014 | 446 | 0.020 |
Why?
| | Islets of Langerhans | 1 | 2016 | 833 | 0.020 |
Why?
| | Gene Expression | 1 | 2015 | 1490 | 0.020 |
Why?
| | Molecular Sequence Data | 2 | 2005 | 2930 | 0.020 |
Why?
| | Translocation, Genetic | 1 | 2010 | 115 | 0.020 |
Why?
| | Blotting, Western | 1 | 2011 | 1187 | 0.020 |
Why?
| | Oligodendrocyte Transcription Factor 2 | 1 | 2009 | 23 | 0.020 |
Why?
| | Antigens, Surface | 2 | 2005 | 157 | 0.020 |
Why?
| | Cell Separation | 2 | 2005 | 307 | 0.020 |
Why?
| | Neuroglia | 1 | 2009 | 172 | 0.020 |
Why?
| | Olfactory Bulb | 1 | 2009 | 97 | 0.020 |
Why?
| | Fetus | 1 | 2011 | 803 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2014 | 2145 | 0.020 |
Why?
| | Coronaviridae Infections | 1 | 1986 | 3 | 0.020 |
Why?
| | G(M1) Ganglioside | 1 | 1986 | 8 | 0.010 |
Why?
| | DNA, Neoplasm | 1 | 2006 | 163 | 0.010 |
Why?
| | Blotting, Southern | 1 | 2005 | 85 | 0.010 |
Why?
| | Cell Transplantation | 1 | 2005 | 39 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2016 | 4557 | 0.010 |
Why?
| | Transgenes | 1 | 2005 | 189 | 0.010 |
Why?
| | CREB-Binding Protein | 1 | 2005 | 34 | 0.010 |
Why?
| | Mesoderm | 1 | 2005 | 150 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1782 | 0.010 |
Why?
| | Transcriptional Activation | 1 | 2006 | 383 | 0.010 |
Why?
| | Spleen | 1 | 2005 | 508 | 0.010 |
Why?
| | Body Patterning | 1 | 2003 | 138 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2003 | 540 | 0.010 |
Why?
| | Amino Acid Motifs | 1 | 2003 | 224 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2003 | 245 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2014 | 8265 | 0.010 |
Why?
| | Chromatography, Affinity | 1 | 2000 | 85 | 0.010 |
Why?
| | HLA-DQ Antigens | 1 | 2000 | 173 | 0.010 |
Why?
| | HLA-DR Antigens | 1 | 2000 | 220 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2003 | 1370 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2003 | 699 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2003 | 2155 | 0.010 |
Why?
| | Binding Sites | 1 | 2000 | 1329 | 0.010 |
Why?
| | Kidney | 1 | 2003 | 1495 | 0.010 |
Why?
| | Aged | 1 | 2014 | 25913 | 0.010 |
Why?
| | Centrifugation, Density Gradient | 1 | 1986 | 40 | 0.000 |
Why?
| | Glycosphingolipids | 1 | 1986 | 7 | 0.000 |
Why?
| | Mice, Inbred A | 1 | 1986 | 48 | 0.000 |
Why?
| | Immune Sera | 1 | 1986 | 77 | 0.000 |
Why?
| | Mice, Inbred DBA | 1 | 1986 | 187 | 0.000 |
Why?
| | Epithelium | 1 | 1986 | 314 | 0.000 |
Why?
| | Colitis | 1 | 1986 | 280 | 0.000 |
Why?
|
|
Ernst's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|